Takato Yomoda
Omuta, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
PRABITAS study design: a pragmatic, randomized phase III trial of bi-weekly versus conventional trifluridine/tipiracil plus bevacizumab for metastatic colorectal cancer.
Journal: ESMO gastrointestinal oncology
Published: August 30, 2024
Mismatch repair proteins expression and tumor-infiltrating T-cells in colorectal cancer.
Journal: Oncology letters
Published: January 26, 2022
Investigation of clinicopathological characters and gene expression features in colorectal signet-ring cell carcinoma utilizing CMS classification.
Journal: Molecular and clinical oncology
Published: June 03, 2020
Mesocolic hernia following retroperitoneal laparoscopic radical nephrectomy: A case report.
Journal: International journal of surgery case reports
Published: June 24, 2019
ASO Author Reflections: Analysis of PD-L1 Expression and Immunoscore in Colorectal Cancer.
Journal: Annals of surgical oncology
Published: April 05, 2019
Correction to: The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells.
Journal: Annals of surgical oncology
Published: January 30, 2019
The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells.
Journal: Annals of surgical oncology
Published: August 27, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026